Lund­beck fund backs a $50M launch round for SNIPR Bio­me, a new brand of CRISPR Cas biotech

The ear­ly-stage ven­ture arm for the Lund­beck Foun­da­tion has launched a biotech start­up that has set sail on the vast mi­cro­bio­me sea. The new com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.